Tag Archives: Johnson

Expert witness: Johnson & Johnson’s role in opioid crisis may be ‘worse’ than Purdue’s

Dr. Andrew Kolodny, the co-director of the Opioid Policy Research Collaborative at Brandeis University, made the comments during the 11th day of the historic trial in Oklahoma that is aimed at holding Johnson & Johnson and its subsidiaries responsible for the state’s opioid epidemic. “Until I had an opportunity to review discovery documents,” Kolodny testified,… Read More »

Johnson & Johnson, AbbVie shore up Imbruvica's CLL lead with Gazyva combo win

Add another indication for Imbruvica in chronic lymphocytic leukemia to the list. On Monday, partners AbbVie and Johnson & Johnson said the standout drug had picked up another FDA approval in the disease, this time in combination with Roche’s Gazyva. The agency greenlighted the pair for previously untreated CLL or small lymphocytic lymphoma (SLL). The… Read More »